Hologic, Inc. logo
Hologic, Inc. (HOLX)
Compare

Hologic, Inc. (HOLX) Price History:24.08%(TTM)

Compare

The price cagr for Hologic, Inc. (HOLX) is +24.08% over the latest trailing 12-month period. The comparable SPY value is +20.75%. Year-to-date price return is +1.94%. Price CAGR uses adjusted close price history and excludes dividends.

Current Price

$76.01

+$0.00 (+0.00%)

Previous Close: $76.01

Today's Trading

Open
$76.01
Day High
$76.01
Day Low
$76.01
Volume
101.96M
Avg Volume
N/A

52-Week Position

100%

of the 52-week price range

From 52-week high
-0.08%
From 52-week low
+46.45%

52-Week Price Range

52-Week Low

$51.90

Jul 15, 2025

Current Price

$76.01

100% of range

52-Week High

$76.07

Apr 6, 2026

Low (+46.45% from current)(-0.08% from current) High

Price Returns by Period

1 Day

+0.00%

7 Days

+0.00%

30 Days

+0.00%

YTD

+1.94%

1 Year

+16.69%

vs 52W High

-0.08%

HOLX Price Chart

End-of-day pricesAdvanced chart →
HOLX$76.01 17.70%as of Apr 7, 2026

Long-Term Performance (CAGR)

Price CAGR (3Y)

-2.83%

Price CAGR (5Y)

+0.84%

Total Return CAGR (3Y)

-2.83%

Total Return CAGR (5Y)

+0.84%

CAGR (Compound Annual Growth Rate) shows the annualized return over the specified period. Total Return includes dividends reinvested.

Key Price Statistics

Current Price$76.01
Previous Close$76.01
Day Range$76.01 - $76.01
52-Week Range$51.90 - $76.07
Volume101.96M
Average VolumeN/A
Market Cap$16.97B
% from 52W High-0.08%
Data as of Wednesday, June 10, 2026

About Hologic, Inc.

Hologic, Inc. is a medical technology company focused on designing, producing, and marketing a diverse range of diagnostic tests, medical imaging systems, and surgical solutions. Its core mission is to enhance women's health through proactive detection and effective treatment, serving patients in the United States, across Europe, the Asia-Pacific region, and various other international markets. The company operates through four distinct business units: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. Within its Diagnostics segment, Hologic provides Aptima molecular diagnostic assays for identifying infectious microorganisms, alongside Aptima viral load tests for conditions like HIV, Hepatitis C, and Hepatitis B. It also offers Aptima and Panther Fusion SARS-CoV-2 assays for detecting the virus, the ThinPrep System for cytology applications, and the Rapid Fetal Fibronectin Test to help clinicians assess the likelihood of premature birth. Furthermore, the company supplies various diagnostic tests for Group B Streptococcus. The Breast Health division delivers advanced imaging and analytical solutions, including 2D and 3D digital mammography systems with accompanying reading workstations. This segment also features minimally invasive breast biopsy guidance systems and devices, products for marking and localizing breast biopsy sites, specimen radiology tools, ultrasound solutions, connectivity options, and products supporting breast-conserving surgical procedures. For GYN Surgical needs, Hologic offers the NovaSure Endometrial Ablation System, designed to manage abnormal uterine bleeding, and the MyoSure Hysteroscopic Tissue Removal System for the excision of uterine fibroids, polyps, and other pathologies. Additionally, the Fluent Fluid Management System facilitates liquid distention during diagnostic and operative hysteroscopic interventions. The Skeletal Health segment includes the Horizon DXA, a dual-energy X-ray system, and the Fluoroscan Insight FD mini C-arm, which is utilized for minimally invasive orthopedic surgical procedures. Hologic distributes its comprehensive product portfolio through a combination of its dedicated direct sales and service teams, as well as via independent distributors and sales representatives. Established in 1985, Hologic, Inc. maintains its corporate headquarters in Marlborough, Massachusetts.

Marlborough, MA
7,063 employees
Healthcare / Medical - Instruments & Supplies
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Paul Malenchini